IL165397A0 - Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders - Google Patents
Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disordersInfo
- Publication number
- IL165397A0 IL165397A0 IL16539703A IL16539703A IL165397A0 IL 165397 A0 IL165397 A0 IL 165397A0 IL 16539703 A IL16539703 A IL 16539703A IL 16539703 A IL16539703 A IL 16539703A IL 165397 A0 IL165397 A0 IL 165397A0
- Authority
- IL
- Israel
- Prior art keywords
- cyclothiocarbamative
- modulators
- derivatives
- treatment
- skin disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A61Q7/02—Preparations for inhibiting or slowing hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Birds (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39188502P | 2002-06-25 | 2002-06-25 | |
| PCT/US2003/019860 WO2004000230A2 (en) | 2002-06-25 | 2003-06-23 | Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL165397A0 true IL165397A0 (en) | 2006-01-15 |
Family
ID=30000769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16539703A IL165397A0 (en) | 2002-06-25 | 2003-06-23 | Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7268149B2 (no) |
| EP (1) | EP1531824A4 (no) |
| JP (1) | JP2005535628A (no) |
| KR (1) | KR20050013627A (no) |
| CN (1) | CN1665510A (no) |
| AR (1) | AR040644A1 (no) |
| AU (1) | AU2003245657A1 (no) |
| BR (1) | BR0312039A (no) |
| CA (1) | CA2489815A1 (no) |
| CO (1) | CO5680439A2 (no) |
| CR (1) | CR7608A (no) |
| EC (1) | ECSP055572A (no) |
| IL (1) | IL165397A0 (no) |
| MX (1) | MXPA04012420A (no) |
| NO (1) | NO20045214L (no) |
| RU (1) | RU2005101625A (no) |
| TW (1) | TW200400950A (no) |
| WO (1) | WO2004000230A2 (no) |
| ZA (1) | ZA200410407B (no) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6391907B1 (en) * | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
| US6355648B1 (en) * | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
| US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
| US6509334B1 (en) | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
| UA73119C2 (en) * | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
| IL165395A0 (en) * | 2002-06-25 | 2006-01-15 | Wyeth Corp | Use of thio-oxubdile derivatives in treatment of hormone-related conditions |
| ATE409699T1 (de) * | 2004-04-08 | 2008-10-15 | Wyeth Corp | Verfahren zur minimierung von thioamidverunreinigungen |
| EP1732921B1 (en) | 2004-04-08 | 2008-11-05 | Wyeth | Thioamide derivatives as progesterone receptor modulators |
| AU2005238520B2 (en) * | 2004-04-27 | 2011-09-08 | Wyeth | Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| AU2005237520B2 (en) * | 2004-04-27 | 2012-01-19 | Wyeth | Purification of progesterone receptor modulators |
| WO2006014476A1 (en) * | 2004-07-07 | 2006-02-09 | Wyeth | Cyclic progestin regimens and kits |
| ATE541853T1 (de) * | 2004-08-13 | 2012-02-15 | Wyeth Llc | Tanaproget-derivate, metaboliten und verwendungen dafür |
| AU2005285355A1 (en) * | 2004-08-20 | 2006-03-23 | Wyeth | Progesterone receptor structure |
| EP1874278B1 (en) | 2005-04-28 | 2009-06-24 | Wyeth | Compositions containing micronized tanaproget |
| BRPI0610433A2 (pt) * | 2005-04-28 | 2010-11-23 | Wyeth Corp | forma polimórfica ii de tanaproget, processos para preparar a mesma, e para preparar forma micronizada de um composto, composição farmacêutica, método de preparação de uma composição farmacêutica, e, uso da forma polimórfica ii de tanaproget ou da forma micronizada |
| PE20061322A1 (es) * | 2005-04-28 | 2006-12-28 | Wyeth Corp | Forma purificada de tanaproget |
| ATE460937T1 (de) * | 2005-04-28 | 2010-04-15 | Wyeth Corp | Mikronisierte tanaproget zusammensetzungen und verfahren zu ihrer herstellung |
| MX2007013467A (es) * | 2005-04-28 | 2008-01-21 | Wyeth Corp | Tanaproget micronizado y composiciones que contienen el mismo. |
| TW200716137A (en) | 2005-06-09 | 2007-05-01 | Wyeth Corp | Tanaproget compositions containing ethinyl estradiol |
| AU2007338102A1 (en) * | 2006-12-22 | 2008-07-03 | F. Hoffmann-La Roche Ag | Processes for the preparation of (3R, 4R) -N- (4 -chlorophenyl) -1- (2, 2-difluoroethyl) -N' - [2-fluoro-4- (2-oxo-1 (2H) -pyridinyl) phenyl] -3, 4-pyrrolidinedicarboxamide |
| JP2011507853A (ja) * | 2007-12-20 | 2011-03-10 | テバ ウィメンズ ヘルス インコーポレイテッド | 緊急避妊のための投与量レジメンならびに薬学的組成物およびパッケージ |
| DE102008022221A1 (de) * | 2008-05-06 | 2009-11-12 | Universität des Saarlandes | Inhibitoren der humanen Aldosteronsynthase CYP11B2 |
| EP2664325A1 (en) * | 2012-05-16 | 2013-11-20 | PregLem S.A. | Methods for preventing or treating androgen mediated diseases |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985000519A1 (en) | 1983-07-29 | 1985-02-14 | Duke University | Method of treating androgen-related disorders |
| GB2310660A (en) | 1996-03-01 | 1997-09-03 | Merck & Co Inc | Benzoxazinone oxytocin receptor antagonists |
| ATE318578T1 (de) * | 1998-10-23 | 2006-03-15 | Aventis Pharma Sa | Zubereitungen zur topischen applikation von antiandrogen wirksamen substanzen |
| US6355648B1 (en) | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
| US6509334B1 (en) * | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
| US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
| WO2001015108A1 (en) | 1999-08-26 | 2001-03-01 | Automotive Systems Lyboratory, Inc. | Magnetic sensor |
| US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
| BR0013597A (pt) * | 1999-08-27 | 2002-07-16 | Ligand Pharm Inc | Compostos e métodos moduladores de receptor de androgênio |
| US7119207B2 (en) * | 2000-04-10 | 2006-10-10 | Pfizer Inc | Benzoamide piperidine containing compounds and related compounds |
| CA2405089A1 (en) | 2000-04-10 | 2001-10-18 | Pfizer Products Inc. | Benzoamide piperidine containing compounds and related compounds |
| UA73119C2 (en) * | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
-
2003
- 2003-06-23 AR AR20030102239A patent/AR040644A1/es not_active Application Discontinuation
- 2003-06-23 CN CN038151944A patent/CN1665510A/zh active Pending
- 2003-06-23 IL IL16539703A patent/IL165397A0/xx unknown
- 2003-06-23 TW TW092116986A patent/TW200400950A/zh unknown
- 2003-06-23 CA CA002489815A patent/CA2489815A1/en not_active Abandoned
- 2003-06-23 AU AU2003245657A patent/AU2003245657A1/en not_active Abandoned
- 2003-06-23 RU RU2005101625/04A patent/RU2005101625A/ru not_active Application Discontinuation
- 2003-06-23 US US10/601,968 patent/US7268149B2/en not_active Expired - Fee Related
- 2003-06-23 KR KR10-2004-7021150A patent/KR20050013627A/ko not_active Application Discontinuation
- 2003-06-23 BR BR0312039-2A patent/BR0312039A/pt not_active IP Right Cessation
- 2003-06-23 EP EP03739286A patent/EP1531824A4/en not_active Withdrawn
- 2003-06-23 JP JP2004516187A patent/JP2005535628A/ja active Pending
- 2003-06-23 MX MXPA04012420A patent/MXPA04012420A/es unknown
- 2003-06-23 WO PCT/US2003/019860 patent/WO2004000230A2/en not_active Application Discontinuation
-
2004
- 2004-11-29 NO NO20045214A patent/NO20045214L/no not_active Application Discontinuation
- 2004-12-08 CR CR7608A patent/CR7608A/es not_active Application Discontinuation
- 2004-12-23 ZA ZA200410407A patent/ZA200410407B/en unknown
-
2005
- 2005-01-20 CO CO05004456A patent/CO5680439A2/es not_active Application Discontinuation
- 2005-01-25 EC EC2005005572A patent/ECSP055572A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7268149B2 (en) | 2007-09-11 |
| AU2003245657A1 (en) | 2004-01-06 |
| MXPA04012420A (es) | 2005-04-19 |
| BR0312039A (pt) | 2005-06-28 |
| AR040644A1 (es) | 2005-04-13 |
| ECSP055572A (es) | 2005-04-18 |
| NO20045214L (no) | 2005-03-17 |
| CO5680439A2 (es) | 2006-09-29 |
| CN1665510A (zh) | 2005-09-07 |
| EP1531824A4 (en) | 2005-09-21 |
| WO2004000230A2 (en) | 2003-12-31 |
| TW200400950A (en) | 2004-01-16 |
| RU2005101625A (ru) | 2005-06-27 |
| JP2005535628A (ja) | 2005-11-24 |
| US20040014798A1 (en) | 2004-01-22 |
| ZA200410407B (en) | 2007-07-25 |
| EP1531824A2 (en) | 2005-05-25 |
| CR7608A (es) | 2006-07-14 |
| CA2489815A1 (en) | 2003-12-31 |
| KR20050013627A (ko) | 2005-02-04 |
| WO2004000230A3 (en) | 2004-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL165397A0 (en) | Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders | |
| AU2003286567A8 (en) | Methods for the treatment of skin disorders | |
| ZA200505272B (en) | Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines | |
| IL178142A0 (en) | Methods of using and compositions comprising immunomodulatory compounos for the treatment and management of skin diseases or disorders | |
| IL165394A0 (en) | Use of thio-oxindole derivatives in treatment of skin disorders | |
| IL173123A0 (en) | System and method for the photodynamic treatment of burns, wounds, and related skin disorders | |
| EP1641378A4 (en) | METHOD AND DEVICES FOR TREATING SKIN Lions | |
| IL172621A0 (en) | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto | |
| EP1509279A4 (en) | DEVICE AND METHOD FOR THE TREATMENT OF HEART DISEASES | |
| AU2003300939A1 (en) | Methods for the treatment of pain and traumatic injury using benzamides and compositions containing the same | |
| EP1699431A4 (en) | COMPOSITIONS FOR THE TREATMENT OF EARLIER DISEASES AND APPLICATION PROCEDURES | |
| AU2003300791A1 (en) | Combination therapy for the treatment of pain | |
| AU2003278775A8 (en) | Porifera-based therapeutic compositions for treating and preventing skin diseases | |
| ZA200410409B (en) | Use of thio-oxindole derivatives in treatment of hormonerelated conditions | |
| ZA200410157B (en) | Methods of treating gastrointestinal and genitorinary pain disorders using vanilafaxin and derivatives | |
| AU2003210730A8 (en) | Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders | |
| AU2003209150A8 (en) | Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases | |
| AU2003270536A1 (en) | Method of treating skin disorders | |
| EP1539100A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS | |
| GB0101146D0 (en) | Treatment of skin conditions | |
| GB0111441D0 (en) | Method and kit for the treatment of cosmetic skin conditions | |
| SI1680405T1 (sl) | Bengamidni derivati in njihova uporaba za zdravljenje rakavih bolezni | |
| GB0316940D0 (en) | Treatment of skin and other medical conditions | |
| GB0216097D0 (en) | Treatment of proliferative disorders | |
| AU2003297570A1 (en) | Treatment of skin diseases |